0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Gastrointestinal Cancer
 41-60 of 117 Articles
Editorial | 
Manish A. Shah, MD; Jaffer A. Ajani, MD
JAMA. 2010;303(17):1753-1754. doi:10.1001/jama.2010.553.

Preliminary Communication |  FREE
William F. Anderson, MD; M. Constanza Camargo, MSc; Joseph F. Fraumeni, MD; et al.
JAMA. 2010;303(17):1723-1728. doi:10.1001/jama.2010.496.

JAMA Patient Page |  FREE
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2010;303(17):1771. doi:10.1001/jama.303.17.1771.
Includes: Supplemental Content

Review | 
The GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group*
JAMA. 2010;303(17):1729-1737. doi:10.1001/jama.2010.534.
Includes: Supplemental Content

Medical News & Perspectives | 
Anita Slomski
JAMA. 2010;303(14):1356-1357. doi:10.1001/jama.2010.360.

Original Contribution |  FREE
Katherine L. Kahn, MD; John L. Adams, PhD; Jane C. Weeks, MD, MSc; et al.
JAMA. 2010;303(11):1037-1045. doi:10.1001/jama.2010.272.
Includes: Supplemental Content

Review | 
Susanna C. Larsson, PhD; Nicola Orsini, PhD; Alicja Wolk, DMSc
JAMA. 2010;303(11):1077-1083. doi:10.1001/jama.2010.263.
Includes: CME

Original Contribution |  FREE
Fay Kastrinos, MD, MPH; Bhramar Mukherjee, PhD; Nabihah Tayob, MS; et al.
JAMA. 2009;302(16):1790-1795. doi:10.1001/jama.2009.1529.
Includes: Supplemental Content

Commentary | 
Hemant K. Roy, MD; Laura K. Bianchi, MD
JAMA. 2009;302(15):1696-1697. doi:10.1001/jama.2009.1499.

Editorial | 
Alfred I. Neugut, MD, PhD
JAMA. 2009;302(6):688-689. doi:10.1001/jama.2009.1145.

Original Contribution |  FREE
Andrew T. Chan, MD, MPH; Shuji Ogino, MD, PhD; Charles S. Fuchs, MD, MPH
JAMA. 2009;302(6):649-658. doi:10.1001/jama.2009.1112.

Medical News & Perspectives | 
Tracy Hampton, PhD
JAMA. 2009;302(4):373-374. doi:10.1001/jama.2009.1021.

Editorial | 
Emily Finlayson, MD, MS
JAMA. 2009;301(23):2498-2499. doi:10.1001/jama.2009.864.

Preliminary Communication |  FREE
Scott A. Waldman, MD, PhD; Terry Hyslop, PhD; Stephanie Schulz, PhD; et al.
JAMA. 2009;301(7):745-752. doi:10.1001/jama.2009.141.
Includes: Supplemental Content

Review | 
Edoardo Botteri, MSc; Simona Iodice, MSc; Vincenzo Bagnardi, PhD; et al.
JAMA. 2008;300(23):2765-2778. doi:10.1001/jama.2008.839.
Includes: Supplemental Content

Original Contribution |  FREE
Virginia G. Kaklamani, MD, DSc; Kari B. Wisinski, MD; Maureen Sadim, BS; et al.
JAMA. 2008;300(13):1523-1531. doi:10.1001/jama.300.13.1523.

Editorial | 
Hemant K. Roy, MD; Laura K. Bianchi, MD
JAMA. 2008;300(12):1459-1461. doi:10.1001/jama.300.12.1459.

The World in Medicine | 
Joan Stephenson, PhD
JAMA. 2008;300(11):1291. doi:10.1001/jama.300.11.1291-a.

Editorial | 
Boris Pasche, MD, PhD
JAMA. 2008;299(21):2564-2565. doi:10.1001/jama.299.21.2564.

Original Contribution |  FREE
Jennifer A. Chan, MD, MPH; Jeffrey A. Meyerhardt, MD, MPH; Donna Niedzwiecki, PhD; et al.
JAMA. 2008;299(21):2515-2523. doi:10.1001/jama.299.21.2515.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Biomarkers of Fluorouracil Toxicity Insight From the PETACC-8 Trial
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncology
Invited Commentary  | 
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer Requirements for Accurate Prognosis Assessment
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncology
Original Investigation  | 
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab A Post Hoc Analysis of the PETACC-8 Trial
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.